[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Beam Therapeutics Inc (BEAM)

Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Beam Therapeutics Inc 238 Main Street Cambridge MA 02142 USA

https://beamtx.com Employees: 511 P: 857-327-8775

Sector:

Medical

Description:

Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 3,320,751
Enterprise Value, $K 3,025,811
Shares Outstanding, K 102,746
Float, K 98,842
% Float 96.20%
Short Interest, K 22,221
Short Float 21.63%
Days to Cover 11.05
Short Volume Ratio 0.49
% of Insider Shareholders 3.80%
% of Institutional Shareholders 99.68%

Financials:

Annual Sales, $ 139,740 K
Annual Net Income, $ -79,990 K
Last Quarter Sales, $ 114,110 K
Last Quarter Net Income, $ 244,300 K
EBIT, $ -383,700 K
EBITDA, $ -377,360 K

Growth:

1-Year Return 87.36%
3-Year Return -3.03%
5-Year Return -55.06%
5-Year Revenue Growth 698,600.06%
5-Year Earnings Growth -14.49%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.91 on 05/07/26
Next Earnings Date 08/04/26
Earnings Per Share ttm -3.44
EPS Growth vs. Prev Qtr -810.00%
EPS Growth vs. Prev Year 26.61%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 02/04/14
Dividend Payout Ratio 0.00%

BEAM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -29.55%
Return-on-Assets % -22.96%
Profit Margin % -57.24%
Debt/Equity 0.00
Price/Sales 23.14
Price/Cash Flow N/A
Price/Book 2.58
Book Value/Share 12.20
Interest Coverage -0.30
60-Month Beta 2.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.